Suppr超能文献

严重 COVID-19 感染:机构审查和文献综述。

Severe COVID-19 infection: An institutional review and literature overview.

机构信息

Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States of America.

Department of Engineering, Pennsylvania State University, State College, Pennsylvania, United States of America.

出版信息

PLoS One. 2024 Aug 20;19(8):e0304960. doi: 10.1371/journal.pone.0304960. eCollection 2024.

Abstract

BACKGROUND

Our study aimed to describe the group of severe COVID-19 patients at an institutional level, and determine factors associated with different outcomes.

METHODS

A retrospective chart review of patients admitted with severe acute hypoxic respiratory failure due to COVID-19 infection. Based on outcomes, we categorized 3 groups of severe COVID-19: (1) Favorable outcome: progressive care unit admission and discharge (2) Intermediate outcome: ICU care (3) Poor outcome: in-hospital mortality.

RESULTS

Eighty-nine patients met our inclusion criteria; 42.7% were female. The average age was 59.7 (standard deviation (SD):13.7). Most of the population were Caucasian (95.5%) and non-Hispanic (91.0%). Age, sex, race, and ethnicity were similar between outcome groups. Medicare and Medicaid patients accounted for 62.9%. The average BMI was 33.5 (SD:8.2). Moderate comorbidity was observed, with an average Charlson Comorbidity index (CCI) of 3.8 (SD:2.6). There were no differences in the average CCI between groups(p = 0.291). Many patients (67.4%) had hypertension, diabetes (42.7%) and chronic lung disease (32.6%). A statistical difference was found when chronic lung disease was evaluated; p = 0.002. The prevalence of chronic lung disease was 19.6%, 27.8%, and 40% in the favorable, intermediate, and poor outcome groups, respectively. Smoking history was associated with poor outcomes (p = 0.04). Only 7.9% were fully vaccinated. Almost half (46.1%) were intubated and mechanically ventilated. Patients spent an average of 12.1 days ventilated (SD:8.5), with an average of 6.0 days from admission to ventilation (SD:5.1). The intermediate group had a shorter average interval from admission to ventilator (77.2 hours, SD:67.6), than the poor group (212.8 hours, SD:126.8); (p = 0.001). The presence of bacterial pneumonia was greatest in the intermediate group (72.2%), compared to the favorable group (17.4%), and the poor group (56%); this was significant (p<0.0001). In-hospital mortality was seen in 28.1%.

CONCLUSION

Most patients were male, obese, had moderate-level comorbidity, a history of tobacco abuse, and government-funded insurance. Nearly 50% required mechanical ventilation, and about 28% died during hospitalization. Bacterial pneumonia was most prevalent in intubated groups. Patients who were intubated with a good outcome were intubated earlier during their hospital course, with an average difference of 135.6 hours. A history of cigarette smoking and chronic lung disease were associated with poor outcomes.

摘要

背景

本研究旨在描述机构层面的严重 COVID-19 患者群体,并确定与不同结局相关的因素。

方法

对因 COVID-19 感染导致严重急性低氧性呼吸衰竭而入院的患者进行回顾性图表审查。根据结局,我们将严重 COVID-19 患者分为 3 组:(1)预后良好:入住并出院于普通病房(2)预后中等:入住 ICU(3)预后不良:院内死亡。

结果

89 名患者符合纳入标准;42.7%为女性。平均年龄为 59.7(标准差(SD):13.7)。大多数患者为白种人(95.5%)和非西班牙裔(91.0%)。年龄、性别、种族和民族在结局组之间相似。医疗保险和医疗补助患者占 62.9%。平均 BMI 为 33.5(SD:8.2)。观察到中度合并症,平均 Charlson 合并症指数(CCI)为 3.8(SD:2.6)。各组间平均 CCI 无差异(p = 0.291)。许多患者(67.4%)患有高血压、糖尿病(42.7%)和慢性肺部疾病(32.6%)。当评估慢性肺部疾病时,发现了统计学差异;p = 0.002。预后良好、中等和不良的组中慢性肺部疾病的患病率分别为 19.6%、27.8%和 40%。吸烟史与不良结局相关(p = 0.04)。只有 7.9%的患者完全接种了疫苗。近一半(46.1%)接受了插管和机械通气。患者平均通气 12.1 天(SD:8.5),从入院到通气的平均时间为 6.0 天(SD:5.1)。与预后不良组(212.8 小时,SD:126.8)相比,中等组(77.2 小时,SD:67.6)的入院至呼吸机间隔更短(p = 0.001)。中间组的细菌性肺炎发生率最高(72.2%),与预后良好组(17.4%)和预后不良组(56%)相比,差异显著(p<0.0001)。住院期间死亡率为 28.1%。

结论

大多数患者为男性,肥胖,合并中度疾病,有吸烟史,且拥有政府资助的保险。近 50%的患者需要机械通气,约 28%的患者在住院期间死亡。细菌性肺炎在插管组中最为常见。预后良好的插管患者在住院期间更早地进行插管,平均差异为 135.6 小时。吸烟史和慢性肺部疾病与不良结局相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11335168/ae5ef61d5a7c/pone.0304960.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验